Elanco Animal Health Incorporated announced on January 23, 2025, that Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is now available for veterinarians to order in the U.S. This product is designed to deliver the broadest parasite protection of its kind, covering six different types of parasites in a single monthly chewable tablet.
Credelio Quattro protects against fleas, ticks, heartworms, roundworms, hookworms, and tapeworms, addressing a significant need for comprehensive parasite control. Elanco's research indicates that 94% of dog owners prioritize proactive treatment for intestinal worms, and Credelio Quattro aims to meet these expectations with its effectiveness and coverage.
This launch is a key milestone in Elanco's innovation strategy, as Credelio Quattro is one of six potential blockbuster products available in the U.S. The product is expected to strengthen Elanco's market presence and contribute to continued growth in the parasiticide segment, with studies showing 100% efficacy against tapeworms and faster tick-killing action compared to competitors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.